Correlates and prognostic value of left atrial strain in transcatheter edge-to-edge repair for degenerative mitral regurgitation

European Heart Journal - Cardiovascular Imaging

11 September 2025
Organised by: Logo
ESC Journals IMAGING Echocardiography Interventional Cardiology VALVULAR, MYOCARDIAL, PERICARDIAL, PULMONARY, CONGENITAL HEART DISEASE Valvular Heart Disease

Abstract

AbstractAims

Data are scarce regarding the implications of left atrial (LA) strain (LAS) in patients undergoing transcatheter edge-to-edge repair (TEER) for degenerative mitral regurgitation (MR). We explored pre-, intra-, and post-procedural aspects according to LAS status in this setting.

Methods and results

A single-centre, retrospective analysis was performed that included 367 individuals (median age 82 years, 62.4% male) referred to isolated, first-time interventions. Stratified by median LAS at baseline (18.5%) and at 1-month post-procedure (29.0%), the cohort was evaluated for all-cause mortality, heart failure (HF) hospitalizations, and significant MR and/or functional incapacitation persistence during the first post-interventional year. Subjects with below-median preprocedural LAS presented more often with acute HF and/or haemodynamic instability, displayed higher interventional risk and atrial fibrillation/flutter prevalence, and had more pronounced chamber dysfunction/dilatation. Procedural features were unaffected by baseline LAS allocation, leading to >97% technical success rate and >80% freedom from above-moderate MR or New York Heart Association Class III–IV in both groups. Worse baseline LAS was associated with higher rates, cumulative incidences, and risks of deaths and/or HF hospitalizations. Per exploratory analysis, the excess composite risk (hazard ratio 2.16, 95% confidence interval 1.16–4.00, P = 0.015) was confined to stable, chronic HF cases with significant LA dilatation. One-month post-procedural LAS directly correlated with its baseline counterpart, and a more impaired value—rather than the change in LAS—conferred heightened deaths/HF readmissions risk.

Conclusion

Although unrelated to procedural feasibility, safety, or efficacy, worse LAS identifies higher-risk patients prone to experience a less favourable clinical course post-TEER for degenerative MR.

Contributors

Alon Shechter
Alon Shechter

Author

Rabin Medical Centre Petah Tikva , Israel

Raj R Makkar
Raj R Makkar

Author

Cedars-Sinai Health System Los Angeles , United States of America

ESC 365 is supported by